AZNIX Mutual Fund

NAV$12.91

Fund Essentials - as of Jan 30, 2026

Net Assets
$2.1B
Expense Ratio
0.90%
Dividend Yield (Current)
6.66%
Holdings
347
Inception Date
Feb 28, 2007
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Monthly
SEC 30-Day Yield
PRO

Performance

YTD+8.84%
1 Year+17.20%
3 Year+13.32%
5 Year+6.23%
10 Year+9.48%

Asset Allocation

Stocks: 64.21%
Bonds: 34.33%
Other: 1.46%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
NVDANvidia Corp3.25%
AAPLApple Inc2.39%
GOOGL'alphabet Inc., Class 'a''1.95%
AMZNAmazon.Com Inc1.95%
MSFTMicrosoft Corp 4.100 Feb 06 371.91%
Top 10 Concentration: 16.73%Report Date: Jan 30, 2026
Download all 347 holdings for AZNIX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.66%
Frequency
Monthly
Latest Distribution
$0.07
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how AZNIX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

AZNIX Mutual Fund Overview

AZNIX Mutual Fund (Virtus Income & Growth Fund Institutional Class) is managed by Virtus Investment Partners with $2.15B in net assets. AZNIX expense ratio is 0.90%, holding 347 positions across sectors including Other, Information Technology, Health Care. Inception date: 2007-02-28.

AZNIX performance shows a YTD return of 8.84%. The 1-year return is 17.20% and the 5-year return is 6.23%. AZNIX dividend yield stands at 6.66%, paid monthly.

AZNIX top holdings include Nvidia Corp (3.3%), Apple Inc (2.4%), 'alphabet Inc., Class 'a'' (1.9%), Amazon.Com Inc (1.9%), Microsoft Corp 4.100 Feb 06 37 (1.9%). View all AZNIX holdings, sector breakdown, or dividend history.

AZNIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. AZNIX alternatives are available via the screener, along with tax-loss harvesting opportunities.